- Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trialsHuang Jun; Zhao Yongzhao; Xu Yong; Zhu Yanjie; Huang Jiale; Liu Yanna; Zhao Liying; Li Zhijia; Liu Hao; Wang Qi long; Qi XiaolongONCOTARGET, 2016, 7(23): 34824-34831.
- A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?Ciliberto Domenico; Staropoli Nicoletta; Caglioti Francesca; Gualtieri Simona; Fiorillo Lucia; Chiellino Silvia; De Angelis Antonina Maria; Mendicino Francesco; Botta Cirino; Caraglia Michele; Tassone Pierfrancesco; Tagliaferri PierosandroCancer Biology and Therapy, 2015, 16(8): 1148-1159.
- Management of advanced gastric cancer: An overview of major findings from meta-analysisQi Xiaolong; Liu Yanna; Wang Wei; Cai Danxian; Li Wende; Hui Jialiang; Liu Chuan; Zhao Yanxia; Li GuoxinONCOTARGET, 2016, 7(47): 78180-78205.
期刊论文
The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
21阅读
